Evolving Epidemiology of Hepatitis C Virus in the United States

被引:158
作者
Klevens, R. Monina [1 ]
Hu, Dale J. [1 ]
Jiles, Ruth [1 ]
Holmberg, Scott D. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA
关键词
INJECTION-DRUG USERS; HUMAN-IMMUNODEFICIENCY-VIRUS; B VIRAL-HEPATITIS; NEW-YORK; NON-A; RISK BEHAVIORS; LIVER-DISEASE; BLOOD-DONORS; YOUNG-ADULTS; INFECTION;
D O I
10.1093/cid/cis393
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The impact of hepatitis C virus (HCV) infection on health and medical care in the United States is a major problem for infectious disease physicians. Although the incidence of HCV infection has declined markedly in the past 2 decades, chronic infection in 3 million or more residents now accounts for more disease and death in the United States than does human immunodeficiency virus (HIV)/AIDS. Current trends in the epidemiology of HCV infection include an apparent increase in young, often suburban heroin injection drug users who initiate use with oral prescription opioid drugs; infections in nonhospital healthcare (clinic) settings; and sexual transmission among HIV-infected persons. Infectious disease physicians will increasingly have the responsibility of diagnosing and treating HCV patients. An understanding of how these patients were infected is important for determining whom to screen and treat.
引用
收藏
页码:S3 / S9
页数:7
相关论文
共 56 条
[1]   The importance of preventing hepatitis C virus infection among injection drug users in the United States [J].
Alter, MJ ;
Moyer, LA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 :S6-S10
[2]   Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004 [J].
Amon, Joseph J. ;
Garfein, Richard S. ;
Ahdieh-Grant, Linda ;
Armstrong, Gregory L. ;
Ouellet, Lawrence J. ;
Latka, Mary H. ;
Vlahov, David ;
Strathdee, Steffanie A. ;
Hudson, Sharon M. ;
Kerndt, Peter ;
Jarlais, Don Des ;
Williams, Ian T. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1852-1858
[3]   The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 [J].
Armstrong, Gregory L. ;
Wasley, Annemarie ;
Simard, Edgar P. ;
McQuillan, Geraldine M. ;
Kuhnert, Wendi L. ;
Alter, Miriam J. .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (10) :705-714
[4]   Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications [J].
Arrese, Marco ;
Riquelme, Arnoldo ;
Soza, Alejandro .
ANNALS OF HEPATOLOGY, 2010, 9 :S112-S118
[5]  
Blatt LM, 2000, J VIRAL HEPATITIS, V7, P196
[6]   Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004 [J].
Burt, Richard D. ;
Hagan, Holly ;
Garfein, Richard S. ;
Sabin, Keith ;
Weinbaum, Cindy ;
Thiede, Hanne .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2007, 84 (03) :436-454
[7]   Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection [J].
Busch, MP ;
Glynn, SA ;
Wright, DJ ;
Hirschkorn, D ;
Laycock, ME ;
McAuley, J ;
Tu, YL ;
Giachetti, C ;
Gallarda, J ;
Heitman, J ;
Kleinman, SH .
TRANSFUSION, 2005, 45 (12) :1853-1863
[8]   Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006 [J].
Campsmith, Michael L. ;
Rhodes, Philip H. ;
Hall, H. Irene ;
Green, Timothy A. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (05) :619-624
[9]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[10]  
Church D., 2011, Morbidity and Mortality Weekly Report, V60, P1457